Stone JH, Wallace Z, Perugino CA, et al. Final Results of an Open Label Phase 2 Study of a Reversible B Cell Inhibitor, Xmab®5871, in IgG4-Related Disease. ACR 2017, abstract 4L.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
mei 2024
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE